The study involves research of three study drugs, given alone or in combination. The combination of the study drugs is referred to as T-Plex. The purpose of the study is to learn if the study drugs are well tolerated and effective in treating your type of cancer.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Jared Weiss
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Other Cancers)
23-1443
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
